Novo Nordisk acquires collaborative partner for USD 1.8bn

Novo Nordisk and Emisphere Technologies have agreed on the terms of a deal which will place the US firm under Danish care for the sum of USD 1.8bn.
Photo: Jacob Gronholt-Pedersen/REUTERS / X04292
Photo: Jacob Gronholt-Pedersen/REUTERS / X04292
BY ELISZABETH MØNSTED JOHANSEN, TRANSLATED BY NIELSINE NIELSEN

A 13-year-old collaboration between Novo Nordisk and Emisphere Technologies now culminates in the acquisition of the latter by the former.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
Must be at least 8 characters, including three of: Uppercase, lowercase, numbers, symbols
Must contain at least 2 characters
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Share article

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

Newsletter terms

Front page now

Further reading